The RNA component of human telomerase
- PMID: 7544491
- DOI: 10.1126/science.7544491
The RNA component of human telomerase
Abstract
Eukaryotic chromosomes are capped with repetitive telomere sequences that protect the ends from damage and rearrangements. Telomere repeats are synthesized by telomerase, a ribonucleic acid (RNA)-protein complex. Here, the cloning of the RNA component of human telomerase, termed hTR, is described. The template region of hTR encompasses 11 nucleotides (5'-CUAACCCUAAC) complementary to the human telomere sequence (TTAGGG)n. Germline tissues and tumor cell lines expressed more hTR than normal somatic cells and tissues, which have no detectable telomerase activity. Human cell lines that expressed hTR mutated in the template region generated the predicted mutant telomerase activity. HeLa cells transfected with an antisense hTR lost telomeric DNA and began to die after 23 to 26 doublings. Thus, human telomerase is a critical enzyme for the long-term proliferation of immortal tumor cells.
Similar articles
-
Functional characterization and developmental regulation of mouse telomerase RNA.Science. 1995 Sep 1;269(5228):1267-70. doi: 10.1126/science.7544492. Science. 1995. PMID: 7544492
-
Functional reconstitution of wild-type and mutant Tetrahymena telomerase.Genes Dev. 1994 Mar 1;8(5):563-75. doi: 10.1101/gad.8.5.563. Genes Dev. 1994. PMID: 7523243
-
Allosteric inhibitors of telomerase: oligonucleotide N3'-->P5' phosphoramidates.Nucleic Acids Res. 2002 Jan 15;30(2):559-68. doi: 10.1093/nar/30.2.559. Nucleic Acids Res. 2002. PMID: 11788719 Free PMC article.
-
The implication of telomerase activity and telomere stability for replicative aging and cellular immortality (Review).Oncol Rep. 1998 Sep-Oct;5(5):1043-52. doi: 10.3892/or.5.5.1043. Oncol Rep. 1998. PMID: 9683806 Review.
-
Telomeres, telomerase and senescence.Bioessays. 1990 Aug;12(8):363-9. doi: 10.1002/bies.950120803. Bioessays. 1990. PMID: 2241933 Review.
Cited by
-
Telomere maintenance and the DNA damage response: a paradoxical alliance.Front Cell Dev Biol. 2024 Oct 17;12:1472906. doi: 10.3389/fcell.2024.1472906. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39483338 Free PMC article.
-
A homozygous telomerase T-motif variant resulting in markedly reduced repeat addition processivity in siblings with Hoyeraal Hreidarsson syndrome.Blood. 2013 May 2;121(18):3586-93. doi: 10.1182/blood-2012-08-447755. Epub 2013 Mar 28. Blood. 2013. PMID: 23538340 Free PMC article.
-
Alternative splicing is a developmental switch for hTERT expression.Mol Cell. 2021 Jun 3;81(11):2349-2360.e6. doi: 10.1016/j.molcel.2021.03.033. Epub 2021 Apr 13. Mol Cell. 2021. PMID: 33852895 Free PMC article.
-
Targeting telomerase with radiolabeled inhibitors.Eur J Med Chem. 2017 Jan 5;125:117-129. doi: 10.1016/j.ejmech.2016.09.028. Epub 2016 Sep 10. Eur J Med Chem. 2017. PMID: 27657809 Free PMC article.
-
Evolution of Cancer Vaccines-Challenges, Achievements, and Future Directions.Vaccines (Basel). 2021 May 20;9(5):535. doi: 10.3390/vaccines9050535. Vaccines (Basel). 2021. PMID: 34065557 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources